NASDAQ:MLAB
Mesa Laboratories Inc.
Mesa Laboratories Inc.'s revenue grew 3.4% in fiscal 2026 to $249.1M while operating margin rose to 7.4%. Free cash flow was $39.6M, 15.9% of revenue, and the diluted share count rose 2.7%.Summary generated from Mesa Laboratories Inc.'s SEC filings. Latest annual report filed Jun 3, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$249.1M
Revenue growth+3.4%
Revenue, 5-yr CAGR+13.2%
Gross margin63.5%
Operating margin7.4%
Net margin2.7%
ROIC4.8%
Return on equity3.9%
Debt / equity0.36
Free cash flow$39.6M
FCF margin15.9%
Share count change+2.7%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 184 | 219 | 216 | 241 | 249 |
| Operating income | 5 | 3 | −272 | 16 | 19 |
| Net income | 2 | 1 | −254 | −2 | 7 |
| Free cash flow | 35 | 23 | 42 | 43 | 40 |
Recent filings
- 4Insider transaction report
Sep 11, 2026 - 4Insider transaction report
Sep 11, 2026 - 8-KResults of a shareholder vote
Sep 8, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 8-KCurrent report
Jul 30, 2026 - DEF 14AProxy statement
Jul 22, 2026 - 8-KDirector or officer change
Jun 15, 2026